Portland, OR -- (SBWIRE) -- 10/06/2017 -- Paediatrics medicines belong to the special category of medicines that are prescribed for the paediatrics group of patients, in different indications. These drugs are prescribed for different diseases such as anorexia, birth defects, asthma and others. Several acts such as Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) has been passed to increase the R&D investments on paediatric medicines. The drivers that drive the paediatrics medicines market growth are a rise in prevalence of diseases such as diabetes and obesity in children along with awareness in people. In addition, the rise in government funding and awareness programs also fuel the market growth. However, low disposable income and side effects such as a headache along with anxiety restraints the market growth. Technological developments in the field of paediatrics medicine will prove as a future opportunity for the market growth.

Get TOC and Sample Copy: https://www.alliedmarketresearch.com/request-toc-and-sample/3774

The report segments the market on the basis of type and region. Based on the type, the market can be segmented into short-term illness such as ear infection, upper respiratory infections & others, and chronic illness such as cystic fibrosis, diabetes, and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players in the market are Lupin, GlaxoSmithKline plc., Pfizer Inc., Sanofi S.A., F. Hoffman-La Roche Ltd, Abbott Laboratories, Heron Therapeutics Inc., Eli Lilly & Company, Novartis A.G, Merck Co.Ltd., and Cipla Inc.

Get 20% Discount on this report

Key Benefits

-The study provides an in-depth analysis of the global pediatrics medicine market along with the current trends and future estimations to elucidate the imminent investment pockets.

-Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.

-Comprehensive quantitative analysis of the industry is provided for the period of 20162023 to assist stakeholders to capitalize on the prevailing market opportunities.

-Extensive analysis of the key segments of the industry helps in understanding the trends in types of pediatrics medicine across the globe.

-Key market players and their strategies have been provided to understand the competitive outlook of the industry.